Bio-Matrix Scientific Group, Inc. BMSN
We continue our coverage of BMSN this Tuesday morning following six consecutive sessions of positive moves for the stock. Last Monday, we focused on BMSN, having already seen upwards of 2400% in gains from the stock to that point. From Monday’s low of .0075, to the high Friday at .015, we added another 100% rip to our resume’ of gains since we’ve been tracking BMSN.
Currently on the chart, we have a very favorable set-up. The 50DMA is approaching the 200DMA, setting up for a Golden Cross, which is something we always like to see.
While the chart is beginning to appear top-heavy, we have yet to observe any of the signs of the stock being overbought. We continue to see higher lows and higher highs being maintained. However it is at this point that we’ll exercise extreme caution, because as many other stocks in this position have taught us in the past, a wave of profit-taking could cause a sell-off at any time. At that point, we’d like to see a penny hold as support for BMSN to continue to hold our interest.
Entest BioMedical Inc. ENTB
We’ve been keeping ENTB in our extended watchlist consistently since January 15th. Shortly following that date we saw a low of .001. The stock has been gaining steadily since that time, and hit a high of .0077 on Friday. In exactly one month’s time, ENTB managed to increase 670% in value for us, and we couldn’t be more pleased.
It’s worthwhile to note that ENTB is under the same management as our previously mentioned winner, BMSN.
The chart is exhibiting similar pattern to BMSN as well, so we want to look out for the 50DMA to continue to curl up to the 200DMA toward a potential Golden Cross.
BIOF and PEIX, are our two ethanol plays that have continued to bring us solid gains. Friday’s session was no exception. PEIX traded in a range from .393-.469, a gain of 19%, while the range on BIOF was 5.678-6.84, a 20.5% jump.
PPHM, ODP, OMX,